Literature DB >> 21163706

Mini-vesicostomy in the management of PUV after valve ablation.

Monika Nanda1, Monika Bawa, K L Narasimhan.   

Abstract

AIM: To determine the usefulness of infra-umbilical mini-vesicostomy in infants with posterior urethral valves (PUV), in developing countries. This new technique facilitates clean intermittent catheterization (CIC) and overnight bladder drainage, which have been effectively used for the treatment of valve bladders in the developed world.
METHODS: A retrospective analysis of the records of three infants who underwent a mini-vesicostomy between 2005-2009 was done. All were put on CIC in the neonatal period. Monitoring of renal parameters, bladder function and structural changes in the bladder was done before and after 4 years of CIC.
RESULTS: All three showed a decrease in upper tract dilatation, improvement in cortical function and improvement of bladder compliance at the end of 4 years. Two patients are on CIC through vesicostomy and can pass a good stream of urine per urethraly, and in one the vesicostomy has been closed.
CONCLUSION: Mini-vesicostomy is a useful option to allow CIC on a long-term basis in children with PUV. There were no complications with this technique in this small group of patients, and it has been well accepted by their families.
Copyright © 2010 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21163706     DOI: 10.1016/j.jpurol.2010.11.004

Source DB:  PubMed          Journal:  J Pediatr Urol        ISSN: 1477-5131            Impact factor:   1.830


  2 in total

1.  Comparison of early neonatal valve ablation with vesicostomy in patient with posterior urethral valve.

Authors:  Seyed Mohammad Vahid Hosseini; Mohammad Zarenezhad; Mansour Kamali; Saeed Gholamzadeh; Babak Sabet; Farzaneh Alipour
Journal:  Afr J Paediatr Surg       Date:  2015 Oct-Dec

2.  Posterior Urethral Valves; A single Center Experience.

Authors:  Alireza Mirshemirani; Ahmad Khaleghnejad; Mohsen Rouzrokh; Afsaneh Sadeghi; Leila Mohajerzadeh; Mustafa Sharifian
Journal:  Iran J Pediatr       Date:  2013-10       Impact factor: 0.364

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.